nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—SLC7A11—forelimb zeugopod—type 1 diabetes mellitus	0.077	0.228	CbGeAlD
Sulfasalazine—ACAT1—islet of Langerhans—type 1 diabetes mellitus	0.0167	0.0495	CbGeAlD
Sulfasalazine—Olsalazine—IFNG—type 1 diabetes mellitus	0.0136	0.865	CrCbGaD
Sulfasalazine—ACAT1—nephron tubule—type 1 diabetes mellitus	0.0135	0.0399	CbGeAlD
Sulfasalazine—ACAT1—cardiovascular system—type 1 diabetes mellitus	0.0121	0.0358	CbGeAlD
Sulfasalazine—ACAT1—kidney—type 1 diabetes mellitus	0.0118	0.0351	CbGeAlD
Sulfasalazine—ACAT1—pancreas—type 1 diabetes mellitus	0.0118	0.0348	CbGeAlD
Sulfasalazine—PLA2G1B—islet of Langerhans—type 1 diabetes mellitus	0.0117	0.0347	CbGeAlD
Sulfasalazine—SLC7A11—islet of Langerhans—type 1 diabetes mellitus	0.0103	0.0304	CbGeAlD
Sulfasalazine—TBXAS1—cardiovascular system—type 1 diabetes mellitus	0.0101	0.0299	CbGeAlD
Sulfasalazine—CHUK—cardiovascular system—type 1 diabetes mellitus	0.00902	0.0267	CbGeAlD
Sulfasalazine—TBXAS1—lymphoid tissue—type 1 diabetes mellitus	0.0085	0.0252	CbGeAlD
Sulfasalazine—PLA2G1B—cardiovascular system—type 1 diabetes mellitus	0.00848	0.0251	CbGeAlD
Sulfasalazine—PLA2G1B—kidney—type 1 diabetes mellitus	0.00829	0.0246	CbGeAlD
Sulfasalazine—PLA2G1B—pancreas—type 1 diabetes mellitus	0.00824	0.0244	CbGeAlD
Sulfasalazine—SLC46A1—lymphoid tissue—type 1 diabetes mellitus	0.00758	0.0224	CbGeAlD
Sulfasalazine—CHUK—lymphoid tissue—type 1 diabetes mellitus	0.00758	0.0224	CbGeAlD
Sulfasalazine—SLC7A11—kidney—type 1 diabetes mellitus	0.00726	0.0215	CbGeAlD
Sulfasalazine—SLC7A11—pancreas—type 1 diabetes mellitus	0.00722	0.0214	CbGeAlD
Sulfasalazine—ALOX5—islet of Langerhans—type 1 diabetes mellitus	0.00702	0.0208	CbGeAlD
Sulfasalazine—IKBKB—cardiovascular system—type 1 diabetes mellitus	0.00613	0.0181	CbGeAlD
Sulfasalazine—PPARG—islet of Langerhans—type 1 diabetes mellitus	0.00527	0.0156	CbGeAlD
Sulfasalazine—IKBKB—lymphoid tissue—type 1 diabetes mellitus	0.00515	0.0152	CbGeAlD
Sulfasalazine—ALOX5—cardiovascular system—type 1 diabetes mellitus	0.00508	0.015	CbGeAlD
Sulfasalazine—ALOX5—pancreas—type 1 diabetes mellitus	0.00494	0.0146	CbGeAlD
Sulfasalazine—SLCO1B1—kidney—type 1 diabetes mellitus	0.00433	0.0128	CbGeAlD
Sulfasalazine—ALOX5—lymphoid tissue—type 1 diabetes mellitus	0.00427	0.0126	CbGeAlD
Sulfasalazine—PPARG—cardiovascular system—type 1 diabetes mellitus	0.00381	0.0113	CbGeAlD
Sulfasalazine—ABCC2—nephron tubule—type 1 diabetes mellitus	0.00373	0.011	CbGeAlD
Sulfasalazine—PPARG—kidney—type 1 diabetes mellitus	0.00373	0.011	CbGeAlD
Sulfasalazine—PPARG—pancreas—type 1 diabetes mellitus	0.00371	0.011	CbGeAlD
Sulfasalazine—ABCC2—kidney—type 1 diabetes mellitus	0.00328	0.00971	CbGeAlD
Sulfasalazine—PPARG—lymphoid tissue—type 1 diabetes mellitus	0.0032	0.00949	CbGeAlD
Sulfasalazine—CYP3A5—islet of Langerhans—type 1 diabetes mellitus	0.00314	0.00929	CbGeAlD
Sulfasalazine—ABCG2—nephron tubule—type 1 diabetes mellitus	0.00272	0.00806	CbGeAlD
Sulfasalazine—PTGS2—islet of Langerhans—type 1 diabetes mellitus	0.00269	0.00798	CbGeAlD
Sulfasalazine—CYP3A5—nephron tubule—type 1 diabetes mellitus	0.00253	0.00748	CbGeAlD
Sulfasalazine—CYP3A5—kidney—type 1 diabetes mellitus	0.00222	0.00657	CbGeAlD
Sulfasalazine—CYP3A5—pancreas—type 1 diabetes mellitus	0.00221	0.00653	CbGeAlD
Sulfasalazine—Vismodegib—ALB—type 1 diabetes mellitus	0.00211	0.134	CrCbGaD
Sulfasalazine—PTGS1—cardiovascular system—type 1 diabetes mellitus	0.00204	0.00604	CbGeAlD
Sulfasalazine—PTGS1—kidney—type 1 diabetes mellitus	0.00199	0.00591	CbGeAlD
Sulfasalazine—PTGS2—cardiovascular system—type 1 diabetes mellitus	0.00195	0.00577	CbGeAlD
Sulfasalazine—PTGS2—kidney—type 1 diabetes mellitus	0.00191	0.00564	CbGeAlD
Sulfasalazine—PTGS2—pancreas—type 1 diabetes mellitus	0.00189	0.00561	CbGeAlD
Sulfasalazine—PTGS2—lymphoid tissue—type 1 diabetes mellitus	0.00164	0.00485	CbGeAlD
Sulfasalazine—CHUK—Innate Immune System—CD80—type 1 diabetes mellitus	0.000107	0.000166	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—G6PC2—type 1 diabetes mellitus	0.000107	0.000165	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000103	0.00016	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—type 1 diabetes mellitus	0.000103	0.00016	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-DPB1—type 1 diabetes mellitus	0.000103	0.000159	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD79A—type 1 diabetes mellitus	0.000103	0.000159	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CD80—type 1 diabetes mellitus	0.000103	0.000159	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—STAT3—type 1 diabetes mellitus	0.000102	0.000158	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000102	0.000158	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-E—type 1 diabetes mellitus	0.000101	0.000157	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—ALB—type 1 diabetes mellitus	0.000101	0.000157	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—PRKCQ—type 1 diabetes mellitus	0.000101	0.000156	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HLA-DRB1—type 1 diabetes mellitus	0.000101	0.000156	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—EGFR—type 1 diabetes mellitus	0.000101	0.000156	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—type 1 diabetes mellitus	0.000101	0.000156	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000101	0.000156	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—STAT3—type 1 diabetes mellitus	0.000101	0.000156	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	9.99e-05	0.000155	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—NOS1—type 1 diabetes mellitus	9.95e-05	0.000154	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCL11—type 1 diabetes mellitus	9.95e-05	0.000154	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCL20—type 1 diabetes mellitus	9.95e-05	0.000154	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—STAT3—type 1 diabetes mellitus	9.9e-05	0.000153	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ABCC8—type 1 diabetes mellitus	9.83e-05	0.000152	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—VAV1—type 1 diabetes mellitus	9.8e-05	0.000152	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—KCNJ11—type 1 diabetes mellitus	9.79e-05	0.000151	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CTLA4—type 1 diabetes mellitus	9.77e-05	0.000151	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CD80—type 1 diabetes mellitus	9.71e-05	0.00015	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—NOS3—type 1 diabetes mellitus	9.7e-05	0.00015	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-DQA1—type 1 diabetes mellitus	9.49e-05	0.000147	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CHRM2—type 1 diabetes mellitus	9.36e-05	0.000145	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD79A—type 1 diabetes mellitus	9.32e-05	0.000144	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD80—type 1 diabetes mellitus	9.32e-05	0.000144	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—IL6—type 1 diabetes mellitus	9.32e-05	0.000144	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PRKCQ—type 1 diabetes mellitus	9.32e-05	0.000144	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ITPR3—type 1 diabetes mellitus	9.29e-05	0.000144	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—ITPR3—type 1 diabetes mellitus	9.26e-05	0.000143	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ABCC8—type 1 diabetes mellitus	9.24e-05	0.000143	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PRKCQ—type 1 diabetes mellitus	9.15e-05	0.000142	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—EGFR—type 1 diabetes mellitus	9.14e-05	0.000141	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—VDR—type 1 diabetes mellitus	9.13e-05	0.000141	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—VAV1—type 1 diabetes mellitus	9.05e-05	0.00014	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—TYK2—type 1 diabetes mellitus	9.04e-05	0.00014	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—EGFR—type 1 diabetes mellitus	9e-05	0.000139	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—VAV1—type 1 diabetes mellitus	8.89e-05	0.000137	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-DQB1—type 1 diabetes mellitus	8.88e-05	0.000137	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—HBA1—type 1 diabetes mellitus	8.74e-05	0.000135	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SH2B3—type 1 diabetes mellitus	8.72e-05	0.000135	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—APOC3—type 1 diabetes mellitus	8.69e-05	0.000134	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IAPP—type 1 diabetes mellitus	8.66e-05	0.000134	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—APOC3—type 1 diabetes mellitus	8.66e-05	0.000134	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—GCG—type 1 diabetes mellitus	8.64e-05	0.000134	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-DQA1—type 1 diabetes mellitus	8.61e-05	0.000133	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ITPR3—type 1 diabetes mellitus	8.6e-05	0.000133	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD86—type 1 diabetes mellitus	8.55e-05	0.000132	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—GSTT1—type 1 diabetes mellitus	8.54e-05	0.000132	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ITPR3—type 1 diabetes mellitus	8.4e-05	0.00013	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD40LG—type 1 diabetes mellitus	8.38e-05	0.00013	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD8A—type 1 diabetes mellitus	8.29e-05	0.000128	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ITPR3—type 1 diabetes mellitus	8.27e-05	0.000128	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	8.25e-05	0.000128	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—SLC11A1—type 1 diabetes mellitus	8.21e-05	0.000127	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—TYK2—type 1 diabetes mellitus	8.2e-05	0.000127	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CD4—type 1 diabetes mellitus	8.17e-05	0.000126	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—HBA1—type 1 diabetes mellitus	8.1e-05	0.000125	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-DQB1—type 1 diabetes mellitus	8.05e-05	0.000124	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—APOC3—type 1 diabetes mellitus	8.05e-05	0.000124	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-B—type 1 diabetes mellitus	7.97e-05	0.000123	CbGpPWpGaD
Sulfasalazine—ABCC2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	7.96e-05	0.000123	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SH2B3—type 1 diabetes mellitus	7.9e-05	0.000122	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—GSTT1—type 1 diabetes mellitus	7.9e-05	0.000122	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CD86—type 1 diabetes mellitus	7.89e-05	0.000122	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—IL6—type 1 diabetes mellitus	7.88e-05	0.000122	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	7.87e-05	0.000122	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	7.86e-05	0.000122	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—APOC3—type 1 diabetes mellitus	7.86e-05	0.000122	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IAPP—type 1 diabetes mellitus	7.86e-05	0.000122	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CD4—type 1 diabetes mellitus	7.85e-05	0.000121	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—INS—type 1 diabetes mellitus	7.84e-05	0.000121	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—ITPR3—type 1 diabetes mellitus	7.83e-05	0.000121	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—HBA1—type 1 diabetes mellitus	7.78e-05	0.00012	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—KCNJ11—type 1 diabetes mellitus	7.77e-05	0.00012	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD86—type 1 diabetes mellitus	7.75e-05	0.00012	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—IL6—type 1 diabetes mellitus	7.75e-05	0.00012	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—APOC3—type 1 diabetes mellitus	7.73e-05	0.00012	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—ERBB3—type 1 diabetes mellitus	7.71e-05	0.000119	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—STAT3—type 1 diabetes mellitus	7.63e-05	0.000118	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SST—type 1 diabetes mellitus	7.61e-05	0.000118	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD40LG—type 1 diabetes mellitus	7.6e-05	0.000118	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—GSTT1—type 1 diabetes mellitus	7.59e-05	0.000117	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—ADRB1—type 1 diabetes mellitus	7.57e-05	0.000117	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD8A—type 1 diabetes mellitus	7.52e-05	0.000116	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	7.48e-05	0.000116	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL2RA—type 1 diabetes mellitus	7.47e-05	0.000116	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CD4—type 1 diabetes mellitus	7.41e-05	0.000115	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-A—type 1 diabetes mellitus	7.39e-05	0.000114	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—APOC3—type 1 diabetes mellitus	7.33e-05	0.000113	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—IAPP—type 1 diabetes mellitus	7.33e-05	0.000113	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—CAT—type 1 diabetes mellitus	7.31e-05	0.000113	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—KCNJ11—type 1 diabetes mellitus	7.3e-05	0.000113	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-B—type 1 diabetes mellitus	7.23e-05	0.000112	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—ALB—type 1 diabetes mellitus	7.19e-05	0.000111	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—IL6—type 1 diabetes mellitus	7.15e-05	0.000111	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD4—type 1 diabetes mellitus	7.12e-05	0.00011	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—ERBB3—type 1 diabetes mellitus	7.12e-05	0.00011	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CRP—type 1 diabetes mellitus	7.05e-05	0.000109	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—B2M—type 1 diabetes mellitus	7.03e-05	0.000109	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—IL6—type 1 diabetes mellitus	7.03e-05	0.000109	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CCR5—type 1 diabetes mellitus	7e-05	0.000108	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	7e-05	0.000108	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—ERBB3—type 1 diabetes mellitus	6.99e-05	0.000108	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—EGFR—type 1 diabetes mellitus	6.94e-05	0.000107	CbGpPWpGaD
Sulfasalazine—ABCG2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	6.93e-05	0.000107	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—IL6—type 1 diabetes mellitus	6.91e-05	0.000107	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SST—type 1 diabetes mellitus	6.9e-05	0.000107	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—NOS3—type 1 diabetes mellitus	6.88e-05	0.000106	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ADRB1—type 1 diabetes mellitus	6.87e-05	0.000106	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—HLA-A—type 1 diabetes mellitus	6.82e-05	0.000106	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—GCG—type 1 diabetes mellitus	6.8e-05	0.000105	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—GCG—type 1 diabetes mellitus	6.78e-05	0.000105	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL2RA—type 1 diabetes mellitus	6.77e-05	0.000105	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-DRB1—type 1 diabetes mellitus	6.75e-05	0.000104	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-A—type 1 diabetes mellitus	6.7e-05	0.000104	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—TNF—type 1 diabetes mellitus	6.61e-05	0.000102	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ITPR3—type 1 diabetes mellitus	6.56e-05	0.000101	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	6.53e-05	0.000101	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CRP—type 1 diabetes mellitus	6.39e-05	9.88e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—VAV1—type 1 diabetes mellitus	6.34e-05	9.8e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CXCL10—type 1 diabetes mellitus	6.32e-05	9.78e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—GCG—type 1 diabetes mellitus	6.3e-05	9.74e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD80—type 1 diabetes mellitus	6.24e-05	9.65e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—HBA1—type 1 diabetes mellitus	6.18e-05	9.55e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ITPR3—type 1 diabetes mellitus	6.16e-05	9.53e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—GCG—type 1 diabetes mellitus	6.15e-05	9.51e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—APOC3—type 1 diabetes mellitus	6.14e-05	9.49e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-DRB1—type 1 diabetes mellitus	6.12e-05	9.47e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—GCG—type 1 diabetes mellitus	6.05e-05	9.36e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GSTT1—type 1 diabetes mellitus	6.03e-05	9.32e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—NOS2—type 1 diabetes mellitus	5.93e-05	9.18e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	5.92e-05	9.15e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NOS1—type 1 diabetes mellitus	5.9e-05	9.12e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—HBA1—type 1 diabetes mellitus	5.8e-05	8.97e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—APOC3—type 1 diabetes mellitus	5.77e-05	8.92e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CD80—type 1 diabetes mellitus	5.76e-05	8.9e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—CAT—type 1 diabetes mellitus	5.76e-05	8.9e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—EGFR—type 1 diabetes mellitus	5.75e-05	8.9e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—VAV1—type 1 diabetes mellitus	5.75e-05	8.89e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IGF2—type 1 diabetes mellitus	5.74e-05	8.88e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CXCL10—type 1 diabetes mellitus	5.73e-05	8.86e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GSTT1—type 1 diabetes mellitus	5.66e-05	8.76e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD80—type 1 diabetes mellitus	5.65e-05	8.75e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	5.56e-05	8.59e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CD86—type 1 diabetes mellitus	5.53e-05	8.55e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—EGFR—type 1 diabetes mellitus	5.52e-05	8.54e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PRKCQ—type 1 diabetes mellitus	5.52e-05	8.54e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—INS—type 1 diabetes mellitus	5.44e-05	8.41e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—VAV1—type 1 diabetes mellitus	5.36e-05	8.29e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—IL6—type 1 diabetes mellitus	5.33e-05	8.25e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CAT—type 1 diabetes mellitus	5.33e-05	8.24e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—TYK2—type 1 diabetes mellitus	5.26e-05	8.14e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.24e-05	8.11e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—EGFR—type 1 diabetes mellitus	5.22e-05	8.07e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IGF2—type 1 diabetes mellitus	5.2e-05	8.05e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CAT—type 1 diabetes mellitus	5.12e-05	7.92e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CD86—type 1 diabetes mellitus	5.01e-05	7.75e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—EGFR—type 1 diabetes mellitus	5.01e-05	7.75e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—ERBB3—type 1 diabetes mellitus	4.98e-05	7.71e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IFNG—type 1 diabetes mellitus	4.93e-05	7.62e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCR5—type 1 diabetes mellitus	4.9e-05	7.58e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—TYK2—type 1 diabetes mellitus	4.86e-05	7.52e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—INS—type 1 diabetes mellitus	4.85e-05	7.51e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL2RA—type 1 diabetes mellitus	4.83e-05	7.47e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GCG—type 1 diabetes mellitus	4.8e-05	7.43e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—TYK2—type 1 diabetes mellitus	4.77e-05	7.38e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—NOS3—type 1 diabetes mellitus	4.77e-05	7.38e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD4—type 1 diabetes mellitus	4.76e-05	7.36e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—E2F1—type 1 diabetes mellitus	4.76e-05	7.36e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CD86—type 1 diabetes mellitus	4.67e-05	7.23e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ERBB3—type 1 diabetes mellitus	4.52e-05	6.99e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GCG—type 1 diabetes mellitus	4.51e-05	6.98e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IFNG—type 1 diabetes mellitus	4.47e-05	6.91e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—ALB—type 1 diabetes mellitus	4.45e-05	6.88e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCR5—type 1 diabetes mellitus	4.44e-05	6.87e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—IL6—type 1 diabetes mellitus	4.42e-05	6.84e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL1B—type 1 diabetes mellitus	4.4e-05	6.8e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CD4—type 1 diabetes mellitus	4.4e-05	6.8e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL2RA—type 1 diabetes mellitus	4.38e-05	6.77e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL2—type 1 diabetes mellitus	4.38e-05	6.77e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD4—type 1 diabetes mellitus	4.32e-05	6.68e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—NOS3—type 1 diabetes mellitus	4.26e-05	6.58e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—ERBB3—type 1 diabetes mellitus	4.22e-05	6.52e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CCR5—type 1 diabetes mellitus	4.15e-05	6.41e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CAT—type 1 diabetes mellitus	4.07e-05	6.29e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HLA-A—type 1 diabetes mellitus	4.04e-05	6.25e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CD80—type 1 diabetes mellitus	4.03e-05	6.24e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—IL6—type 1 diabetes mellitus	4.01e-05	6.2e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL1B—type 1 diabetes mellitus	3.99e-05	6.17e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL2—type 1 diabetes mellitus	3.97e-05	6.14e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—INS—type 1 diabetes mellitus	3.82e-05	5.91e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CAT—type 1 diabetes mellitus	3.82e-05	5.91e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—INS—type 1 diabetes mellitus	3.81e-05	5.89e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—STAT3—type 1 diabetes mellitus	3.69e-05	5.7e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.68e-05	5.7e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CD80—type 1 diabetes mellitus	3.66e-05	5.65e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—INS—type 1 diabetes mellitus	3.54e-05	5.47e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NOS2—type 1 diabetes mellitus	3.51e-05	5.44e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ALB—type 1 diabetes mellitus	3.5e-05	5.42e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—INS—type 1 diabetes mellitus	3.45e-05	5.34e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CD80—type 1 diabetes mellitus	3.41e-05	5.27e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.4e-05	5.26e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—STAT3—type 1 diabetes mellitus	3.4e-05	5.26e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—INS—type 1 diabetes mellitus	3.4e-05	5.26e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—NOS3—type 1 diabetes mellitus	3.35e-05	5.18e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—EGFR—type 1 diabetes mellitus	3.35e-05	5.18e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—STAT3—type 1 diabetes mellitus	3.34e-05	5.17e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.34e-05	5.17e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.34e-05	5.17e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ALB—type 1 diabetes mellitus	3.24e-05	5.02e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—INS—type 1 diabetes mellitus	3.22e-05	4.98e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ALB—type 1 diabetes mellitus	3.12e-05	4.82e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—NOS3—type 1 diabetes mellitus	3.1e-05	4.8e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—EGFR—type 1 diabetes mellitus	3.09e-05	4.78e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.09e-05	4.77e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—EGFR—type 1 diabetes mellitus	3.04e-05	4.7e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.03e-05	4.69e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—NOS3—type 1 diabetes mellitus	2.98e-05	4.61e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TYK2—type 1 diabetes mellitus	2.88e-05	4.45e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.84e-05	4.39e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL2—type 1 diabetes mellitus	2.83e-05	4.38e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NOS3—type 1 diabetes mellitus	2.83e-05	4.37e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—INS—type 1 diabetes mellitus	2.7e-05	4.17e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CD4—type 1 diabetes mellitus	2.6e-05	4.03e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL6—type 1 diabetes mellitus	2.57e-05	3.98e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.57e-05	3.98e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL2—type 1 diabetes mellitus	2.57e-05	3.97e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—INS—type 1 diabetes mellitus	2.54e-05	3.92e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ALB—type 1 diabetes mellitus	2.47e-05	3.83e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.38e-05	3.69e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—IL6—type 1 diabetes mellitus	2.38e-05	3.68e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—NOS3—type 1 diabetes mellitus	2.37e-05	3.66e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL6—type 1 diabetes mellitus	2.33e-05	3.61e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ALB—type 1 diabetes mellitus	2.32e-05	3.59e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—NOS3—type 1 diabetes mellitus	2.22e-05	3.44e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.17e-05	3.35e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.16e-05	3.34e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—STAT3—type 1 diabetes mellitus	2.02e-05	3.12e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.96e-05	3.04e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—EGFR—type 1 diabetes mellitus	1.83e-05	2.83e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL6—type 1 diabetes mellitus	1.66e-05	2.57e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL6—type 1 diabetes mellitus	1.51e-05	2.33e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—IL6—type 1 diabetes mellitus	1.41e-05	2.18e-05	CbGpPWpGaD
